China Pharma Holdings (CPHI) Work In Process (2017 - 2024)
China Pharma Holdings' (CPHI) quarterly Work In Process came in at $334430.0 in Q3 2024, down 50.59% YoY from $676885.0 in Q4 2023, and up 283.05% on a QoQ basis from $87308.0 in Q2 2024.
China Pharma Holdings (CPHI) Work In Process (2017 - 2024) Analysis & Trends
China Pharma Holdings (CPHI) has 8 years of Work In Process data on file, last reported at $334430.0 in Q3 2024.
- Quarterly Work In Process fell 50.59% year-over-year to $334430.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $334430.0 (down 50.59% YoY) and the FY2023 annual result came in at $413597.0, down 25.77% from the prior year.
- Work In Process rose to $334430.0 in Q3 2024, from $87308.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $676885.0 in Q3 2023 to a low of $87308.0 in Q2 2024.
- A 5-year average of $431457.2 and a median of $423493.0 in 2020 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2020 — Work In Process surged 110.99% — and 2024, when it slumped 76.07%.
- Tracing CPHI's Work In Process over 5 years: stood at $662999.0 in 2020, then fell by 15.97% to $557146.0 in 2021, then changed by 0.0% to $557146.0 in 2022, then decreased by 25.77% to $413597.0 in 2023, then retreated by 19.14% to $334430.0 in 2024.
- The last three Work In Process figures came in at $334430.0 (Q3 2024), $87308.0 (Q2 2024), and $242726.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 334,430.00 |
| Jun 30, 2024 | 87,308.00 |
| Mar 31, 2024 | 242,726.00 |
| Dec 31, 2023 | 413,597.00 |
| Sep 30, 2023 | 676,885.00 |
| Jun 30, 2023 | 364,913.00 |
| Mar 31, 2023 | 319,059.00 |
| Dec 31, 2022 | 557,146.00 |
| Sep 30, 2022 | 615,020.00 |
| Jun 30, 2022 | 356,702.00 |
| Dec 31, 2021 | 557,146.00 |
| Sep 30, 2021 | 442,022.00 |
| Jun 30, 2021 | 461,293.00 |
| Mar 31, 2021 | 341,269.00 |
| Dec 31, 2020 | 662,999.00 |
| Sep 30, 2020 | 433,389.00 |
| Jun 30, 2020 | 644,174.00 |
| Mar 31, 2020 | 256,151.00 |
| Dec 31, 2019 | 314,231.00 |
| Sep 30, 2019 | 382,900.00 |